IP Library Granted Patent US 12,201,342
Granted Patent B2
US 12,201,342 · App. 17/864,855 · Granted Jan 21, 2025

Heat ablation systems, devices and methods for the treatment of tissue

Inventors: Philip S. Levin (Storrs, CT); Jay Caplan (Belmont, MA); Harith Rajagopalan (Wellesley Hills, MA); Mark A. Manasas (Lexington, MA); Andrew Coats (Somerville, MA); J. Christopher Flaherty (Nottingham, NH)
Assignee: Fractyl Health, Inc.
A61B18/082A61B18/04A61B2018/00023A61B2018/00214A61B2018/0022A61B2018/0025A61B2018/00482A61B2018/00494A61B2018/00577A61B2018/00648A61B2018/00744A61B2018/044A61B2018/046A61B18/1492A61M25/04A61M2025/1013F04C2270/0421
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,342
App. No.
17/864,855
Granted
Jan 21, 2025
Kind
B2
Abstract

A system for treatment target tissue comprises an ablation device and an energy delivery unit. The ablation device comprises an elongate tube with an expandable treatment element. The system delivers a thermal dose of energy to treat the target tissue. Methods of treating target tissue are also provided.

Claims (23)

1. A method of treating target tissue, the method comprising:

(1) providing a system comprising an energy delivery unit and an ablation device, wherein the ablation device comprises an elongate tube with a proximal portion, a distal portion, and at least one lumen extending from the proximal portion to the distal portion, and wherein the ablation device further comprises an expandable treatment element mounted to the elongate tube distal portion and in fluid communication with the at least one lumen;

(2) delivering a first thermal dose to a first location of target tissue by delivering energy from the expandable treatment element to the target tissue by (a) delivering a first volume of a first heated fluid via the energy delivery unit to the expandable treatment element to ablate the target tissue, (b) subsequently delivering a first volume of a first cooling fluid via the energy delivery unit to the expandable treatment element to dilute the first volume of the first heated fluid, thereby generating a mixed fluid to cool the target tissue; and

subsequently applying a negative pressure to remove the mixed fluid from the expandable treatment element.

2. The method according to claim 1 , wherein the first cooling fluid is delivered to the expandable treatment element at a temperature at least 10° C. below the temperature of the first heated fluid.

3. The method according to claim 1 , further comprising delivering a second volume of the first cooling fluid to the expandable treatment element to cool the target tissue prior to delivering the first heated fluid to the expandable treatment element.

4. The method according to claim 1 , further comprising moving the expandable treatment element to a second location of target tissue and delivering a second thermal dose to the second location.

5. The method according to claim 4 , wherein the second location is proximal to the first location.

6. The method according to claim 4 , wherein the second location is distal to the first location.

7. The method according to claim 4 , wherein delivering the second thermal dose comprises (a) delivering a second volume of the first heated fluid to the expandable treatment element to ablate the second location of target tissue, and (b) subsequently delivering a second volume of the first cooling fluid to the expandable treatment element to cool the second location target tissue.

8. The method according to claim 7 , further comprising applying a negative pressure via the energy delivery unit subsequently after delivering the second volume of the first cooling fluid to the expandable treatment element to remove the second volume of the first heated fluid and the second volume of the first cooling fluid from the expandable treatment element.

9. The method according to claim 7 , wherein the system further comprises a controller constructed and arranged to modify delivery of the first thermal dose and/or the second thermal dose.

10. The method according to claim 9 , wherein the target tissue comprises a tissue lining of an interior of a hollow body organ and the controller is configured to modulate the temperature of the heated fluid to deliver the first thermal dose and/or the second thermal dose to ablate the tissue lining of the interior of the hollow body organ while avoiding other damage to the hollow body organ.

11. The method according to claim 9 , wherein the controller is configured to modulate the first thermal dose and/or the second thermal dose to ablate the target tissue while avoiding damage to non-target tissue.

12. The method according to claim 1 , wherein the first cooling fluid comprises a temperature less than or equal to 10° C.

13. The method according to claim 1 , wherein the energy delivery unit comprises at least one fluid pump constructed and arranged to deliver both the first cooling fluid and the first heated fluid to the expandable treatment element.

14. The method according to claim 13 , wherein the at least one fluid pump is constructed and arranged to deliver the first cooling fluid and/or the first heated fluid at a flow rate of at least 50 ml/min.

15. The method according to claim 13 , wherein the at least one fluid pump of the energy delivery unit is configured to apply the negative pressure.

16. The method according to claim 2 , wherein the expandable treatment element further comprises a fluid mixing assembly constructed and arranged to cause fluid mixing within the treatment element.

17. The method according to claim 2 , wherein the delivery of the first heated fluid comprises circulating heated fluid through the expandable treatment element.

18. The method according to claim 17 , wherein the first heated fluid is maintained at a relatively constant temperature while in the expandable treatment element.

19. The method according to claim 1 , wherein the system is constructed and arranged to inflate the expandable treatment element within 10 seconds.

20. The method according to claim 1 , wherein the first heated fluid is maintained at a temperature between 65° C. and 99° C.

Assignments (3)
SECURITY INTEREST Recorded Sep 7, 2023
From: FRACTYL HEALTH, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC
Reel/Frame 064840/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2022
From: LEVIN, PHILIP S.; CAPLAN, JAY; RAJAGOPALAN, HARITH; MANASAS, MARK A.; COATS, ANDREW; FLAHERTY, J. CHRISTOPHER
To: FRACTYL LABORATORIES, INC.
Reel/Frame 060860/0702 →
CHANGE OF NAME Recorded Aug 22, 2022
From: FRACTYL LABORATORIES, INC.
To: FRACTYL HEALTH, INC.
Reel/Frame 061298/0933 →
Continuity (5)
Continuation 16438362 · Jun 11, 2019
Continuation 14470503 · Aug 27, 2014
Continuation PCTUS2013028082 · Feb 27, 2013
Provisional Application 61603475 · Feb 27, 2012
Related Publication 20230172649A1 · Jun 8, 2023
References Cited (379)
US 5084044A · Quint · 1992 [cited by applicant]
US 5190540A · Lee · 1993 [cited by applicant]
US 5423754A · Cornelius et al. · 1995 [cited by applicant]
US 5471982A · Edwards et al. · 1995 [cited by applicant]
US 5496311A · Abele et al. · 1996 [cited by applicant]
US 5515100A · Nogo · 1996 [cited by applicant]
US 5542928A · Evans et al. · 1996 [cited by applicant]
US 5549559A · Eshel · 1996 [cited by applicant]
US 5575772A · Lennox · 1996 [cited by applicant]
US 5704934A · Neuwirth et al. · 1998 [cited by applicant]
US 5730719A · Edwards · 1998 [cited by applicant]
US 5800484A · Gough et al. · 1998 [cited by applicant]
US 5827269A · Saadat · 1998 [cited by applicant]
US 5859037A · Whitcomb et al. · 1999 [cited by applicant]
US 5869037A · Crystal et al. · 1999 [cited by applicant]
US 5871525A · Edwards et al. · 1999 [cited by applicant]
US 5879347A · Saadat et al. · 1999 [cited by applicant]
US 5957962A · Wallsten et al. · 1999 [cited by applicant]
US 5964753A · Edwards · 1999 [cited by applicant]
US 6009877A · Edwards · 2000 [cited by applicant]
US 6053937A · Edwards et al. · 2000 [cited by applicant]
US 6056744A · Edwards et al. · 2000 [cited by applicant]
US 6066132A · Chen et al. · 2000 [cited by applicant]
US 6077257A · Edwards et al. · 2000 [cited by applicant]
US 6112123A · Kelleher et al. · 2000 [cited by applicant]
US 6293909B1 · Chu et al. · 2001 [cited by applicant]
US 6325777B1 · Zadno-Azizi et al. · 2001 [cited by applicant]
US 6325798B1 · Edwards et al. · 2001 [cited by applicant]
US 6338726B1 · Edwards et al. · 2002 [cited by applicant]
US 6358245B1 · Edwards et al. · 2002 [cited by applicant]
US 6402744B2 · Edwards et al. · 2002 [cited by applicant]
US 6405732B1 · Edwards et al. · 2002 [cited by applicant]
US 6409723B1 · Edwards · 2002 [cited by applicant]
US 6425887B1 · McGuckin et al. · 2002 [cited by applicant]
US 6443947B1 · Marko et al. · 2002 [cited by applicant]
US 6544226B1 · Gaiser et al. · 2003 [cited by applicant]
US 6673070B2 · Edwards et al. · 2004 [cited by applicant]
US 6712814B2 · Edwards et al. · 2004 [cited by applicant]
US 6802841B2 · Utley et al. · 2004 [cited by applicant]
US 6905496B1 · Ellman et al. · 2005 [cited by applicant]
US 6962587B2 · Johnson et al. · 2005 [cited by applicant]
US 6974456B2 · Edwards et al. · 2005 [cited by applicant]
US 7077841B2 · Gaiser et al. · 2006 [cited by applicant]
US 7111627B2 · Stack et al. · 2006 [cited by applicant]
US 7122031B2 · Edwards et al. · 2006 [cited by applicant]
US 7125407B2 · Edwards et al. · 2006 [cited by applicant]
US 7156860B2 · Wallsten · 2007 [cited by applicant]
US 7165551B2 · Edwards et al. · 2007 [cited by applicant]
US 7241295B2 · Maguire · 2007 [cited by applicant]
US 7326207B2 · Edwards · 2008 [cited by applicant]
US 7371215B2 · Colliou et al. · 2008 [cited by applicant]
US 7387626B2 · Edwards et al. · 2008 [cited by applicant]
US 7422587B2 · Bek et al. · 2008 [cited by applicant]
US 7507234B2 · Utley et al. · 2009 [cited by applicant]
US 7507238B2 · Edwards et al. · 2009 [cited by applicant]
US 7530979B2 · Ganz et al. · 2009 [cited by applicant]
US 7556628B2 · Utley et al. · 2009 [cited by applicant]
US 7585296B2 · Edward et al. · 2009 [cited by applicant]
US 7632268B2 · Utley et al. · 2009 [cited by applicant]
US 7632291B2 · Stephens et al. · 2009 [cited by applicant]
US 7648500B2 · Edwards et al. · 2010 [cited by applicant]
US 7758623B2 · Dzeng et al. · 2010 [cited by applicant]
US 7762977B2 · Porter et al. · 2010 [cited by applicant]
US 7947038B2 · Edwards · 2011 [cited by applicant]
US 7959627B2 · Utley et al. · 2011 [cited by applicant]
US 7993336B2 · Jackson et al. · 2011 [cited by applicant]
US 7997278B2 · Utley et al. · 2011 [cited by applicant]
US 8012149B2 · Jackson et al. · 2011 [cited by applicant]
US 8066689B2 · Mitelberg et al. · 2011 [cited by applicant]
US 8152803B2 · Edwards et al. · 2012 [cited by applicant]
US 8177853B2 · Stack et al. · 2012 [cited by applicant]
US 8192426B2 · Stern et al. · 2012 [cited by applicant]
US 8251992B2 · Utley et al. · 2012 [cited by applicant]
US 8273012B2 · Wallace et al. · 2012 [cited by applicant]
US 8323229B2 · Shin et al. · 2012 [cited by applicant]
US 8364237B2 · Stone et al. · 2013 [cited by applicant]
US 8377055B2 · Jackson et al. · 2013 [cited by applicant]
US 8486005B2 · Yodfat et al. · 2013 [cited by applicant]
US 8641711B2 · Kelly et al. · 2014 [cited by applicant]
US 8740894B2 · Edwards · 2014 [cited by applicant]
US 8790705B2 · Geigle et al. · 2014 [cited by applicant]
US 8932289B2 · Mayse et al. · 2015 [cited by applicant]
US 9364283B2 · Utley et al. · 2016 [cited by applicant]
US 9555020B2 · Pasricha et al. · 2017 [cited by applicant]
US 9615880B2 · Gittard et al. · 2017 [cited by applicant]
US 9757535B2 · Rajagopalan et al. · 2017 [cited by applicant]
US 9844641B2 · Rajagopalan et al. · 2017 [cited by applicant]
US 10232143B2 · Rajagopalan et al. · 2019 [cited by applicant]
US 10299857B2 · Rajagopalan et al. · 2019 [cited by applicant]
US 10349998B2 · Levin et al. · 2019 [cited by applicant]
US 10610663B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10765474B2 · Kadamus et al. · 2020 [cited by applicant]
US 10864352B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10869718B2 · Rajagopalan et al. · 2020 [cited by applicant]
US 10980590B2 · Rajagopalan et al. · 2021 [cited by applicant]
US 10987149B2 · Rajagopalan et al. · 2021 [cited by applicant]
US 11419659B2 · Levin et al. · 2022 [cited by applicant]
US 20020029062A1 · Satake · 2002 [cited by examiner]
US 20020077594A1 · Chien et al. · 2002 [cited by applicant]
US 20020165535A1 · Lesh et al. · 2002 [cited by applicant]
US 20020192162A1 · Green · 2002 [cited by applicant]
US 20030040804A1 · Stack et al. · 2003 [cited by applicant]
US 20030093072A1 · Friedman · 2003 [cited by applicant]
US 20030153905A1 · Edwards et al. · 2003 [cited by applicant]
US 20030233065A1 · Steward et al. · 2003 [cited by applicant]
US 20040082859A1 · Schaer · 2004 [cited by applicant]
US 20040087936A1 · Stern et al. · 2004 [cited by applicant]
US 20040133256A1 · Callister · 2004 [cited by applicant]
US 20040148034A1 · Kagan et al. · 2004 [cited by applicant]
US 20040204768A1 · Geitz · 2004 [cited by applicant]
US 20040215180A1 · Starkebaum et al. · 2004 [cited by applicant]
US 20040215296A1 · Ganz et al. · 2004 [cited by applicant]
US 20040220559A1 · Kramer et al. · 2004 [cited by applicant]
US 20050096638A1 · Starkebaum et al. · 2005 [cited by applicant]
US 20050154386A1 · West et al. · 2005 [cited by applicant]
US 20050165437A1 · Takimoto · 2005 [cited by applicant]
US 20050171524A1 · Stern et al. · 2005 [cited by applicant]
US 20050192652A1 · Cioanta et al. · 2005 [cited by applicant]
US 20050203489A1 · Saadat et al. · 2005 [cited by applicant]
US 20050222558A1 · Baxter et al. · 2005 [cited by applicant]
US 20050245943A1 · Zvuloni et al. · 2005 [cited by applicant]
US 20050251116A1 · Steinke et al. · 2005 [cited by applicant]
US 20050273090A1 · Nieman et al. · 2005 [cited by applicant]
US 20060070631A1 · Scopton et al. · 2006 [cited by applicant]
US 20060118127A1 · Chinn · 2006 [cited by applicant]
US 20060135963A1 · Kick et al. · 2006 [cited by applicant]
US 20060155261A1 · Bek et al. · 2006 [cited by applicant]
US 20060205992A1 · Lubock et al. · 2006 [cited by applicant]
US 20060247683A1 · Danek et al. · 2006 [cited by applicant]
US 20060293742A1 · Dann et al. · 2006 [cited by applicant]
US 20070016262A1 · Gross et al. · 2007 [cited by applicant]
US 20070032788A1 · Edwards et al. · 2007 [cited by applicant]
US 20070060990A1 · Satake · 2007 [cited by examiner]
US 20070100355A1 · Bonde et al. · 2007 [cited by applicant]
US 20080045785A1 · Oyatsu · 2008 [cited by applicant]
US 20080107744A1 · Chu · 2008 [cited by applicant]
US 20080119788A1 · Winter · 2008 [cited by applicant]
US 20080125760A1 · Gilboa · 2008 [cited by applicant]
US 20080125803A1 · Sadamasa et al. · 2008 [cited by applicant]
US 20080147056A1 · Van et al. · 2008 [cited by applicant]
US 20080207994A1 · Gonon · 2008 [cited by applicant]
US 20080243112A1 · De · 2008 [cited by applicant]
US 20080300571A1 · Lepivert · 2008 [cited by applicant]
US 20080319504A1 · Loushin et al. · 2008 [cited by applicant]
US 20090012469A1 · Nita · 2009 [cited by applicant]
US 20090012518A1 · Utley et al. · 2009 [cited by applicant]
US 20090018533A1 · Perkins et al. · 2009 [cited by applicant]
US 20090048593A1 · Ganz et al. · 2009 [cited by applicant]
US 20090069805A1 · Fischer et al. · 2009 [cited by applicant]
US 20090105703A1 · Shadduck · 2009 [cited by applicant]
US 20090270851A1 · Babkin et al. · 2009 [cited by applicant]
US 20100022891A1 · Zuluaga et al. · 2010 [cited by applicant]
US 20100030190A1 · Singh · 2010 [cited by applicant]
US 20100114087A1 · Edwards et al. · 2010 [cited by applicant]
US 20100114325A1 · Yang et al. · 2010 [cited by applicant]
US 20100168561A1 · Anderson · 2010 [cited by applicant]
US 20100168624A1 · Sliwa · 2010 [cited by applicant]
US 20100168676A1 · Datta · 2010 [cited by examiner]
US 20100204673A1 · Miller · 2010 [cited by applicant]
US 20100204688A1 · Hoey et al. · 2010 [cited by applicant]
US 20100217151A1 · Gostout et al. · 2010 [cited by applicant]
US 20100256775A1 · Belhe et al. · 2010 [cited by applicant]
US 20100260703A1 · Yankelson et al. · 2010 [cited by applicant]
US 20110046537A1 · Errico et al. · 2011 [cited by applicant]
US 20110091564A1 · Chu · 2011 [cited by applicant]
US 20110106273A1 · Belhe et al. · 2011 [cited by applicant]
US 20110160648A1 · Hoey · 2011 [cited by applicant]
US 20110172659A1 · Brannan · 2011 [cited by applicant]
US 20110184401A1 · Iwata et al. · 2011 [cited by applicant]
US 20110319809A1 · Smith · 2011 [cited by applicant]
US 20120035604A1 · Takaoka et al. · 2012 [cited by applicant]
US 20120059364A1 · Baust et al. · 2012 [cited by applicant]
US 20120197245A1 · Burnett et al. · 2012 [cited by applicant]
US 20120271277A1 · Fischell et al. · 2012 [cited by applicant]
US 20120271301A1 · Fischell et al. · 2012 [cited by applicant]
US 20130071466A1 · Chancellor et al. · 2013 [cited by applicant]
US 20130178910A1 · Azamian et al. · 2013 [cited by applicant]
US 20140031773A1 · Mikkaichi · 2014 [cited by applicant]
US 20140074077A1 · Lane · 2014 [cited by applicant]
US 20140088529A1 · Bengtson · 2014 [cited by applicant]
US 20140121646A1 · Lodin et al. · 2014 [cited by applicant]
US 20140135661A1 · Garrison et al. · 2014 [cited by applicant]
US 20140163664A1 · Goldsmith · 2014 [cited by applicant]
US 20140255458A1 · Li et al. · 2014 [cited by applicant]
US 20140324037A1 · Hoey et al. · 2014 [cited by applicant]
US 20150045825A1 · Caplan et al. · 2015 [cited by applicant]
US 20150141987A1 · Caplan et al. · 2015 [cited by applicant]
US 20150148738A1 · Caplan et al. · 2015 [cited by applicant]
US 20150359594A1 · Ben-Oren et al. · 2015 [cited by applicant]
US 20160008050A1 · Rajagopalan et al. · 2016 [cited by applicant]
US 20160310200A1 · Wang · 2016 [cited by applicant]
US 20160354144A1 · Caplan et al. · 2016 [cited by applicant]
US 20170191035A1 · Sia et al. · 2017 [cited by applicant]
US 20180221622A1 · Rajagopalan et al. · 2018 [cited by applicant]
US 20200060758A1 · Rajagopalan et al. · 2020 [cited by applicant]
US 20200060942A1 · Rajagopalan et al. · 2020 [cited by applicant]
US 20200155217A1 · Morneau et al. · 2020 [cited by applicant]
US 20200261144A1 · Caplan et al. · 2020 [cited by applicant]
US 20200305972A1 · Kadamus et al. · 2020 [cited by applicant]
US 20200405388A1 · Rajagopalan et al. · 2020 [cited by applicant]
US 20210008336A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210085390A1 · Kadamus et al. · 2021 [cited by applicant]
US 20210137995A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210299404A1 · Rajagopalan et al. · 2021 [cited by applicant]
US 20210307816A1 · Rajagopalan et al. · 2021 [cited by applicant]
CA 2666661C · 2015 [cited by applicant]
CN 1771888A · 2006 [cited by applicant]
CN 101212932A · 2008 [cited by applicant]
EP 1698296A1 · 2006 [cited by applicant]
EP 1886634A1 · 2008 [cited by applicant]
EP 3071286A1 · 2016 [cited by applicant]
JP 2002503512A · 2002 [cited by applicant]
JP 2003520068A · 2003 [cited by applicant]
JP 2004500184A · 2004 [cited by applicant]
JP 2004180934A · 2004 [cited by applicant]
JP 2004523280A · 2004 [cited by applicant]
JP 2005185760A · 2005 [cited by applicant]
JP 2006509536A · 2006 [cited by applicant]
JP 2006136726A · 2006 [cited by applicant]
JP 2007502690A · 2007 [cited by applicant]
JP 2008515464A · 2008 [cited by applicant]
JP 2010506696A · 2010 [cited by applicant]
JP 2010142661A · 2010 [cited by applicant]
JP 2010533036A · 2010 [cited by applicant]
JP 2011517599A · 2011 [cited by applicant]
JP 2013543423A · 2013 [cited by applicant]
JP 2014503256A · 2014 [cited by applicant]
KR 20080013945A · 2008 [cited by applicant]
KR 20110120919A · 2011 [cited by applicant]
WO WO9418896A1 · 1994 [cited by applicant]
WO WO9912489A2 · 1999 [cited by applicant]
WO WO0207628A2 · 2002 [cited by applicant]
WO WO02058577A1 · 2002 [cited by applicant]
WO WO02096327A2 · 2002 [cited by applicant]
WO WO02102453A2 · 2002 [cited by applicant]
WO WO03033045A2 · 2003 [cited by applicant]
WO WO03092609A2 · 2003 [cited by applicant]
WO WO2004064600A2 · 2004 [cited by applicant]
WO WO2006020370A2 · 2006 [cited by applicant]
WO WO2007044244A2 · 2007 [cited by applicant]
WO WO2007067919A2 · 2007 [cited by applicant]
WO WO2008002654A2 · 2008 [cited by applicant]
WO WO2010042461A1 · 2010 [cited by applicant]
WO WO2010125570A1 · 2010 [cited by applicant]
WO WO2011060301A1 · 2011 [cited by applicant]
WO WO2012009486A2 · 2012 [cited by applicant]
WO WO2012099974A2 · 2012 [cited by applicant]
WO WO2013130655A1 · 2013 [cited by applicant]
WO WO2013134541A2 · 2013 [cited by applicant]
WO WO2013159066A1 · 2013 [cited by applicant]
WO WO2014022436A1 · 2014 [cited by applicant]
WO WO2014026055A1 · 2014 [cited by applicant]
WO WO2014055997A1 · 2014 [cited by applicant]
WO WO2014070136A1 · 2014 [cited by applicant]
WO WO2015038973A1 · 2015 [cited by applicant]
WO WO2015077571A1 · 2015 [cited by applicant]
WO WO2015148541A1 · 2015 [cited by applicant]
WO WO2016011269A1 · 2016 [cited by applicant]
WO WO2017004432A1 · 2017 [cited by applicant]
WO WO2018089773A1 · 2018 [cited by applicant]
WO WO2019018362A1 · 2019 [cited by applicant]
WO WO2019136240A1 · 2019 [cited by applicant]
Adams, et al. Theoretical design and evaluation of endoluminal ultrasound applicators for thermal therapy of pancreatic cancer under image guidance. AIP Conference Proceedings 1821, 110002 (2017); doi: http://dx.doi.org… [cited by applicant]
Chathadi, et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. Nov. 2015;82(5):773-81. doi: 10.1016/j.gie.2015.06.027. Epub Aug. 7, 2015. [cited by applicant]
Cherrington, et al. Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease. Gastrointest Endosc Clin N Am. Apr. 2017;27(2):299-311. doi: 10.1016/j.giec.2016.12.002. [cited by applicant]
EP12736438.8 The Extended European Search Report dated Nov. 22, 2016. [cited by applicant]
EP14844285.8 The Extended European Search Report dated Apr. 25, 2017. [cited by applicant]
EP20150391.9 The Extended European Search Report dated Aug. 20, 2020. [cited by applicant]
EP20159816.6 The Extended European Search Report dated Aug. 17, 2020. [cited by applicant]
EP22156535.1 Extended Search Report dated Aug. 4, 2022. [cited by applicant]
European search report and search opinion dated Mar. 8, 2016 for EP Application No. 13825257.2. [cited by applicant]
European search report and search opinion dated Mar. 17, 2016 for EP Application No. 13827149.9. [cited by applicant]
European search report and search opinion dated Aug. 4, 2015 for EP Application No. 13755156.0. [cited by applicant]
European Search Report and Search Opinion dated Aug. 7, 2017 for European Patent Application No. EP14864511.2. [cited by applicant]
European Search Report and Search Opinion dated Aug. 7, 2017 for European Patent Application No. EP15768945.6. [cited by applicant]
European search report and search opinion dated Nov. 25, 2015 for EP Application No. 13777572.2. [cited by applicant]
European search report with written opinion dated Feb. 1, 2018 for EP Application No. 15822378. [cited by applicant]
European search report with written opinion dated Dec. 2, 2016 for EP Application No. 14807116. [cited by applicant]
Final Office action dated Mar. 22, 2019 for U.S. Appl. No. 14/917,243. [cited by applicant]
Final Office action dated Apr. 5, 2019 for U.S. Appl. No. 14/609,334. [cited by applicant]
Final Office action dated Jun. 17, 19 for U.S. Appl. No. 14/609,332. [cited by applicant]
Final Office action dated Jul. 10, 2019 for U.S. Appl. No. 15/274,948. [cited by applicant]
Galvao Neto, et al. Endoscopic Duodenal Mucosal Resurfacing Improves Glycemic and Hepatic Parameters in Patients With Type 2 Diabetes: Data From a First-in-Human Study. Gastroenterology. 829. Apr. 2016, vol. 150, Issue … [cited by applicant]
Grikscheit, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg., 2004, 240:748-754. [cited by applicant]
International search report and written opinion dated Feb. 20, 2015 for PCT Application No. US2014/711601. [cited by applicant]
International search report and written opinion dated Jun. 21, 2013 for PCT Application No. US2013/028082. [cited by applicant]
International search report and written opinion dated Jun. 26, 2015 for PCT Application No. US2015/022293. [cited by applicant]
International search report and written opinion dated Jul. 13, 2012 for PCT Application No. US2012/021739. [cited by applicant]
International search report and written opinion dated Aug. 8, 2013 for PCT Application No. US2013/037485. [cited by applicant]
International Search Report and Written Opinion dated Sep. 22, 2016 for International PCT Patent Application No. PCT/US2016/040512. [cited by applicant]
International search report and written opinion dated Oct. 23, 2015 for PCT/US2015/040775. [cited by applicant]
International search report and written opinion dated Nov. 8, 2013 for PCT Application No. US2013/052786. [cited by applicant]
International search report and written opinion dated Nov. 11, 2013 for PCT Application No. US2013/054219. [cited by applicant]
International search report and written opinion dated Dec. 24, 2014 for PCT Application No. US2014/055514. [cited by applicant]
International search report and written opinion dated Dec. 30, 2013 for PCT Application No. US2013/063753. [cited by applicant]
International search report dated Dec. 3, 2014 for PCT Application No. US2014/040957. [cited by applicant]
International search report with written opinion dated Jan. 9, 2018 for PCT/US2017/061074. [cited by applicant]
Miyawaki, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. Jul. 2002;8(7):738-42. Epub Jun. 17, 2002. [cited by applicant]
Notice of Allowance dated Jul. 7, 2017 for U.S. Appl. No. 15/274,764. [cited by applicant]
Notice of Allowance dated Sep. 14, 2017 for U.S. Appl. No. 15/274,809. [cited by applicant]
Office Action date Jul. 11, 2018 for U.S. Appl. No. 14/917,243. [cited by applicant]
Office Action date Aug. 9, 2018 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Jan. 8, 2018 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office Action dated Jan. 13, 2017 for U.S. Appl. No. 14/609,332. [cited by applicant]
Office action dated Feb. 29, 2016 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office action dated Mar. 7, 2019 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office Action dated Mar. 7, 2017 for U.S. Appl. No. 15/274,764. [cited by applicant]
Office Action dated Mar. 7, 2017 for U.S. Appl. No. 15/274,809. [cited by applicant]
Office action dated Mar. 7, 2019 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Mar. 12, 2015 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Mar. 19, 2018 for U.S. Appl. No. 14/470,503. [cited by applicant]
Office Action dated Mar. 23, 2017 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Mar. 28, 2016 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Apr. 4, 2018 for U.S. Appl. No. 15/156,585. [cited by applicant]
Office action dated May 16, 19 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated May 18, 2018 for U.S. Appl. No. 14/956,710. [cited by applicant]
Office Action dated May 31, 2017 for U.S. Appl. No. 15/274,764. [cited by applicant]
Office action dated Jun. 6, 2019 for U.S. Appl. No. 15/683,713. [cited by applicant]
Office Action dated Jun. 21, 2017 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office Action dated Jun. 21, 2017 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office Action dated Jun. 30, 2017 for U.S. Appl. No. 14/470,503. [cited by applicant]
Office action dated Aug. 5, 2015 for U.S. Appl. No. 13/945,138. [cited by applicant]
“Office action dated Sep. 7, 2018 for U.S. Appl. No. 14/609,332.”. [cited by applicant]
Office Action dated Sep. 23, 2016 for U.S. Appl. No. 14/515,324. [cited by applicant]
“Office action dated Oct. 4, 2018 for U.S. Appl. No. 14/515,324.”. [cited by applicant]
Office Action dated Oct. 7, 2016 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office Action dated Nov. 2, 2017 for U.S. Appl. No. 15/156,585. [cited by applicant]
Office action dated Nov. 2, 2018 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office Action dated Nov. 15, 2016 for U.S. Appl. No. 14/609,334. [cited by applicant]
Office action dated Nov. 16, 2017 for U.S. Appl. No. 14/609,332. [cited by applicant]
Office action dated Nov. 30, 2015 for U.S. Appl. No. 13/945,138. [cited by applicant]
Office action dated Nov. 30, 2017 for U.S. Appl. No. 14/673,565. [cited by applicant]
Office action dated Dec. 17, 2015 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated Dec. 18, 2017 for U.S. Appl. No. 14/515,324. [cited by applicant]
Office action dated Dec. 18, 2018 for U.S. Appl. No. 14/470,503. [cited by applicant]
Office action dated Dec. 19, 2017 for U.S. Appl. No. 13/945,138. [cited by applicant]
PCT/US14/66829 International Search Report dated Feb. 20, 2015. [cited by applicant]
PCT/US2018/042438 International Search Report dated Sep. 14, 2018. [cited by applicant]
PCT/US2019/012338 International Search Report dated Apr. 15, 2019. [cited by applicant]
Rajagopalan, et al. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study. Diabetes Care Dec. 2016; 39(12): 2254-2261. http… [cited by applicant]
Rubino, et al. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. Nov. 2002;236(5):554-9. [cited by applicant]
Sarriá, et al. Morphometric study of the layers of the canine small intestine at five sampling sites. Vet J. Jun. 2012;192(3):498-502. doi: 10.1016/j.tvjl.2011.06.041. Epub Nov. 3, 2011. [cited by applicant]
Semkova, et al. Autologous transplantation of genetically modified iris pigment epithelial cells: A promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad … [cited by applicant]
Sen, et al. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Hum Gene Ther. Oct. … [cited by applicant]
Tolman, et al. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes care 30.3 (2007): 734-743. [cited by applicant]
Tomizawa, et al. Clinical Outcome of Endoscopic Mucosal Resection (EMR) of Sporadic, Non-Ampullary Duodenal Adenoma (SNADA) : Predictor Analysis of Safety and Efficacy From a High Volume U.S. Tertiary Referral Center. G… [cited by applicant]
U.S. Appl. No. 16/438,362 Notice of Allowance dated Apr. 27, 2022. [cited by applicant]
U.S. Appl. No. 14/917,243 Office Action dated Jun. 5, 2020. [cited by applicant]
U.S. Appl. No. 13/945,138 Notice of Allowance dated Dec. 22, 2020. [cited by applicant]
U.S. Appl. No. 14/470,503 Corrected Notice of Allowability dated May 29, 2019. [cited by applicant]
U.S. Appl. No. 14/515,324 Office Action dated Dec. 4, 2020. [cited by applicant]
U.S. Appl. No. 14/609,334 Notice of Allowance dated Dec. 10, 2020. [cited by applicant]
U.S. Appl. No. 14/609,334 Office Action dated Oct. 29, 2020. [cited by applicant]
U.S. Appl. No. 14/673,565 Office Action dated Dec. 24, 2020. [cited by applicant]
U.S. Appl. No. 14/673,565 Office Action dated Jun. 12, 2020. [cited by applicant]
U.S. Appl. No. 15/274,948 Notice of Allowance dated May 14, 2020. [cited by applicant]
U.S. Appl. No. 15/274,948 Office Action dated Nov. 20, 2018. [cited by applicant]
U.S. Appl. No. 15/406,572 Notice of Allowance dated Oct. 28, 2020. [cited by applicant]
U.S. Appl. No. 15/406,572 Office Action dated Apr. 14, 2020. [cited by applicant]
U.S. Appl. No. 15/406,572 Office Action dated Feb. 7, 2019. [cited by applicant]
U.S. Appl. No. 15/406,572 Office Action dated Nov. 15, 2019. [cited by applicant]
U.S. Appl. No. 15/917,480 Notice of Allowance dated Dec. 17, 2020. [cited by applicant]
U.S. Appl. No. 15/917,480 Office Action dated Nov. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/267,771 Notice of Allowance dated Aug. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/438,362 Notice of Allowance dated Jan. 21, 2022. [cited by applicant]
U.S. Appl. No. 16/711,236 Office Action dated Dec. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/900,563 Notice of Allowance dated Dec. 17, 2020. [cited by applicant]
U.S. Appl. No. 16/900,563 Office Action dated Nov. 9, 2020. [cited by applicant]
U.S. Appl. No. 13/945,138 Office Action dated Dec. 10, 2019. [cited by applicant]
U.S. Appl. No. 14/470,503 Notice of Allowance dated Feb. 27, 2019. [cited by applicant]
U.S. Appl. No. 14/515,324 Office Action dated Mar. 31, 2020. [cited by applicant]
U.S. Appl. No. 14/609,334 Office Action dated Jan. 8, 2020. [cited by applicant]
U.S. Appl. No. 14/956,710 Notice of Allowance dated Jan. 9, 2019. [cited by applicant]
U.S. Appl. No. 15/683,713 Notice of Allowance dated Mar. 10, 2020. [cited by applicant]
U.S. Appl. No. 15/683,713 Notice of Allowance dated Nov. 27, 2019. [cited by applicant]
U.S. Appl. No. 15/683,713 Office Action dated Oct. 10, 2019. [cited by applicant]
U.S. Appl. No. 15/917,480 Office Action dated Jan. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/267,771 Office Action dated Feb. 6, 2020. [cited by applicant]
Van Baar, et al. Single Catheter for Duodenal Mucosal Resurfacing Demonstrates Similar Safety Profile with Improved Procedure Time when Compared to Original Dual Catheter: Multicenter Study of Subjects with Type 2 Diabe… [cited by applicant]